Skip to main content
Board of Directors
A word from the CEO
The AGIR program
Platform of Expertise
News & events
To answer health and environmental challenges
Next generation anti-infectives
Active ingredients of natural origin
Issuance of notes convertible into new shares for a maximum amount of €15M. Issuance of a first €2.2 million tranche
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to...
DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019
Major Steven Zumbrun (USAMRIID  , U.S. Department of Defense) presented data on the in vitro...
More press releases
Antibiotic resistance, a global health challenge
The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century
In the Medias
Labiotech.eu | Life at its Limits: Meet the Extremophiles Being Embraced by the Biotech Industry
French biotech Deinove has an enviable collection of thousands of species of rare microbes that the company has been collecting since it...
Arte | Antibiotiques, la fin du miracle ?
Le XXIe siècle marquera-t-il la fin de l’ère des antibiotiques, ramenant la médecine deux cents ans en arrière ? Malgré leurs efforts, les...
More press coverage